Evidence-based review of wormwood safety concerns including thujone neurotoxicity, pregnancy contraindications, and cytochrome P450-mediated drug interactions.
Wormwood (Artemisia absinthium) is contraindicated in pregnancy and breastfeeding due to thujone neurotoxicity and uterine-stimulating effects.
Published wormwood poisoning cases include an infant with metabolic acidosis, a man with measured serum thujone, and a teenager with acute kidney injury.
Evidence-based review of wormwood’s liver-protective effects in animal models, mechanisms, safety concerns, and current evidence gaps.
Trace wormwood’s journey from ancient digestive remedy to absinthe’s notorious ingredient: traditional uses, thujone concerns, and modern evidence gaps.
Evidence-based comparison of wormwood dosage forms, safety limits, thujone concerns, and why clinical data remains limited.
Wormwood’s traditional role as a digestive bitter, its proposed mechanism via bitter taste receptors, safety concerns, and the limited clinical evidence.
Wormwood inhibits carbohydrate-digesting enzymes in the lab. No human trial has tested it for blood sugar, and one 2026 comparison ranked it behind sage.
Wormwood’s traditional role as a bitter appetite stimulant, the dyspepsia evidence from a related Artemisia species, and the safety limits that apply.
Evidence-based review of wormwood antiparasitic mechanisms, covering in vitro, animal, and veterinary studies with safety considerations.
Evidence-based review of wormwood’s antimicrobial effects, mechanisms, and safety considerations based on phytochemical and microbiological studies.
Review of in vitro evidence for wormwood essential oil and extracts against Candida albicans and other fungi, plus safety considerations and research gaps.